Latest From Biotech Now

BIO Rosalind Franklin Award Winner Provides Remarks at #BIOWC16


President and CEO of NexSteppe Anna Rath was presented the 2016 BIO Rosalind Franklin Award at the 2016 World Congress on Industrial Biotechnology in San Diego on Tuesday April 19. BIO established the Rosalind Franklin Award to honor an outstanding woman in the field of industrial biotechnology and bioprocessing. Anna Rath delivered her acceptance remarks at this year’s Conference. BIO captured these remarks and provided some highlights below: …In receiving this award, I read up a bit on the life Read More >

Biofuels & Climate Change  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

Points to Consider about the Center for American Progress Prescription Drug Discussion

health care, medicine

This afternoon, the Center for American Progress (CAP) Action Fund hosted an obviously one-sided discussion on prescription drug pricing. Below are some key questions and points to consider in this important debate that you likely didn’t hear about at the CAP event: Prescription Drugs Only Small Part of Overall Health Spending: Despite the increasingly shrill rhetoric on this issue, the fact remains that prescription drugs are only a small fraction of total health expenditures in Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , ,

How the GE Mushroom Could Change the Debate Around GMOs


Last week, the US Department of Agriculture (USDA) announced that it will not regulate a mushroom that has been genetically modified with the gene-editing tool CRISPR–Cas9. Nature reported on the Agency’s announcement that the GM mushroom can now “be cultivated and sold without passing through the agency’s regulatory process” — making it the first CRISPR-edited organism to receive a green light from the US government. This is a great example of how biotechnology is being used to better our food. In fact, it Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Facing growing pressure, N.Y. insurers agree to lift restrictions on hepatitis c therapies

Wall Street Journal

Last week, we wrote about the mounting evidence of insurer discrimination and coverage denials for patients with certain high-cost health conditions such as HIV and hepatitis C. In many cases, insurers have been denying new hepatitis C treatments to patients unless their livers showed signs of severe damage – despite guidelines from major medical societies recommending the drugs for nearly all hepatitis C patients. Today, the Wall Street Journal reported some good news for hepatitis Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , ,

Integrating the Production of Biofuels and Bioproducts through Advanced Biotechnology


The development of bio-based products (chemicals and materials) has quickly become one of the fastest-growing segments of the biotech industry and represents a significant opportunity to advance the emerging bioeconomy. Bioproducts can be made in a single-product process; however, the co-production of bioproducts alongside biofuels offers a more efficient, cost-effective, and integrated approach to the utilization of our nation’s biomass resources. Within the context of biofuel production, the biorefinery provides substantial opportunities to capitalize on Read More >

Biofuels & Climate Change  |  Leave a comment  |  Email This Post
Tags: , , , , ,